Nemaura Medical Inc. (NMRD)

Nemaura Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Market Capitalization	4	22	102	170	122	185
Market Cap Growth	-84.71%	-78.21%	-39.98%	39.63%	-33.92%	-97.30%
Enterprise Value	24	32	104	163	122	181
PE Ratio	-	-0.89	-7.36	-27.20	-29.31	-41.44
PS Ratio	-4.07	289.00	202.79	-	-	-
PB Ratio	-0.36	-1.88	219.25	20.37	-92.86	82.86
P/FCF Ratio	-0.65	-2.48	-13.70	-24.91	-33.31	-50.68
P/OCF Ratio	-0.66	-2.63	-15.71	-28.38	-35.35	-51.82
EV/Sales Ratio	-16.63	417.83	205.65	-	-	-
EV/EBITDA Ratio	-3.40	-3.94	-14.12	-36.38	-25.79	-40.69
EV/EBIT Ratio	-3.20	-3.74	-13.69	-35.60	-25.49	-40.38
EV/FCF Ratio	-2.65	-3.58	-13.89	-23.89	-33.28	-49.65
Debt / Equity Ratio	-1.10	-1.70	41.17	2.98	-0.70	0.43
Debt / EBITDA Ratio	-2.59	-2.45	-2.61	-5.55	-	-
Debt / FCF Ratio	-2.02	-2.23	-2.57	-3.65	-	-
Quick Ratio	0.02	0.47	0.88	4.98	0.15	2.88
Current Ratio	0.19	0.61	0.98	5.29	0.61	3.48
Asset Turnover	-0.11	0.01	0.02	0	0	0
Interest Coverage	-0.80	-1.50	-1.14	-2.28	0	0
Return on Equity (ROE)	35.32%	212.50%	-2979.46%	-74.88%	316.86%	-199.95%
Return on Assets (ROA)	-121.81%	-172.38%	-62.83%	-17.76%	-340.99%	-93.47%
Return on Capital (ROIC)	-534.72%	-116.79%	-38.52%	-13.78%	363.95%	-201.03%
Earnings Yield	-148.19%	-112.75%	-13.59%	-3.68%	-3.41%	-2.41%
FCF Yield	-229.29%	-40.38%	-7.30%	-4.01%	-3.00%	-1.97%
Buyback Yield / Dilution	-19.90%	-6.39%	-4.94%	-7.10%	-15.01%	87.95%
Total Shareholder Return	-19.90%	-6.39%	-4.94%	-7.10%	-15.01%	87.95%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.